Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients

Peter A. Lee, Michael R. Kelly, John D. Wallin

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.

Original languageEnglish (US)
Pages (from-to)2316-2317
Number of pages2
JournalJAMA: The Journal of the American Medical Association
Issue number21
StatePublished - May 24 1976

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients'. Together they form a unique fingerprint.

Cite this